Les informations concernant les essais cliniques sponsorisés et les résultats sont fournies à titre informatif et ne sont pas destinés à promouvoir un produit ou une utilisation. Les résultats des essais cliniques ont pour objectif de partager les résultats connus au moment de la réalisation de l'étude correspondante. Les résultats ne fournissent pas un examen complet et actuel de la sécurité ni de l'efficacité d'un médicament en particulier sur la base des informations disponibles. Les médecins et les patients doivent se référer à l'autorisation de mise sur le marché approuvée dans leur pays pour connaitre les indications en vigueur localement.
Ces informations n'ont pas pour intention de remplacer les conseils d'un professionnel de santé. Seul un médecin peut déterminer si un médicament spécifique convient ou s'apparente au meilleur traitement pour un patient en particulier. Si vous avez des questions, veuillez consulter un professionnel de santé.
Nom générique |
Nom commercial |
Condition(s) |
Code étude |
ACCÉDER AUX ÉTUDES / PROTOCOLE |
Accéder aux résultats |
---|---|---|---|---|---|
CHOLERA VACCINE, ORAL |
Shancol |
Cholera |
CH-WC-02 |
||
CLOSTRIDIUM DIFFICILE TOXOID VACCINE |
Pas encore disponible |
Clostridium Difficile |
CDI19 (DFI13360) |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Pas encore disponible |
Clostridium Difficile |
H-030-008 |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Pas encore disponible |
Clostridium Difficile |
H-030-009 |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Pas encore disponible |
Clostridium Difficile |
H-030-010 |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Pas encore disponible |
Clostridium Difficile |
H-030-012 |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Pas encore disponible |
Clostridium Difficile |
H-030-014 |
Nom générique |
Nom commercial |
Condition(s) |
Code étude |
ACCÉDER AUX ÉTUDES / PROTOCOLE |
Accéder aux résultats |
---|---|---|---|---|---|
US: DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE ADSORBED, INACTIVATED POLIOVIRUS, HAEMOPHILUS B CONJUGATE [MENINGOCOCCAL PROTEIN CONJUGATE] AND HEPATITIS B [RECOMBINANT] EU: DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), INACTIVATED POLIOVIRUS, AND HAEMOPHILUS TYPE B (MENINGOCOCCAL PROTEIN CONJUGATE) VACCINE (ADSORBED) |
Pas encore disponible |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
PR504 |
||
US: DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE ADSORBED, INACTIVATED POLIOVIRUS, HAEMOPHILUS B CONJUGATE [MENINGOCOCCAL PROTEIN CONJUGATE] AND HEPATITIS B (RECOMBINANT) |
Pas encore disponible |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
PR505 (V419-005) |
||
US: DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE ADSORBED, INACTIVATED POLIOVIRUS, HAEMOPHILUS B CONJUGATE [MENINGOCOCCAL PROTEIN CONJUGATE] AND HEPATITIS B (RECOMBINANT) |
Pas encore disponible |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
PR506 (V419-006) |
||
DTAP |
Tripacel® |
Diphtheria; Tetanus; Pertussis |
P3T06 |
||
DTAP |
Daptacel® |
Diphtheria; Tetanus; Pertussis |
P3T10 |
||
DTAP |
Daptacel® |
Diphtheria; Tetanus; Pertussis |
P3T11 |
||
DTAP-IPV |
COVAXiS®; REPEVAX® |
DDiphtheria; Tetanus; Pertussis; Poliomyelitis |
PERTIMMUN06 |
||
DTAP-HIB VACCINE |
Actacel® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
C5A06 |
||
DTAP-IPV-HB-PRP~T HEXAVALENT VACCINE |
Hexaxim® |
Diphtheria; Tetanus; acellular Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L00052 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L02 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L04 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L10 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L11 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L12 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L15 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L16 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L17 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L21 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L22 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L24 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L26 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L27 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L28 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L31 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L33 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim®/Hexacima®/Hexyon® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L35 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L38 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L39 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L40 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L44 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L45 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L47 |
Pas encore disponible |
|
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L49 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
HXM01C |
||
DTAP-IPV- HEP B-HIB VACCINE |
Pas encore disponible |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
AL201 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Pas encore disponible |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
AL203 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Pas encore disponible |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
AL204 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Pas encore disponible |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
AL205 |
||
DTAP-IPV VACCINE ((DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED AND INACTIVATED POLIOVIRUS VACCINE) |
Quadracel® |
Tetanus; Diphtheria; Pertussis; Poliomyelitis |
M5I02 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I28 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I29 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I34 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I41 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I42 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I43 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I49 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I57 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I59 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I60 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A07 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A08 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A10 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A11 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A15 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A16 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A17 |
Pas encore disponible |
|
DTAP-IPV/HIB VACCINE |
Pediacel® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
A5I15 |
||
DTAP-IPV/HIB VACCINE |
Pediacel® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
A5I16 |
||
DTAP-IPV/HIB VACCINE |
Pediacel® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
A5I19 |
||
DTAP-IPV/HIB VACCINE |
Not yet identified |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
J2I02 (EFC13640) |
||
DTAP-IPV-HIB AND DTAP-IPV- HEP B-HIB VACCINES |
Not yet identified; |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
PRI02C |
||
DTAP-IPV VACCINE; DTIPV VACCINE |
REPEVAX®; |
Diphtheria; Tetanus; Pertussis;Poliomyelitis |
RPV04C |
||
DTAP-IPV- HEP B-HIB VACCINE |
Vaxelis® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
V419-008 |
||
DTWP-HEP B-HIB VACCINE |
SHAN 5® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
DTPwHB-Hib-2007-0200 |
||
DTWP-HEP B-HIB VACCINE |
SHAN 5® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
DTPwHB-HibPMS-2007-010 |
||
DTWP-HEP B-HIB VACCINE |
SHAN 5® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
SH501 |
|
|
DTWP-HEP B-HIB VACCINE |
SHAN 5® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
SH505 |
|
|
Nom générique |
Nom commercial |
Condition(s) |
Code étude |
ACCÉDER AUX ÉTUDES / PROTOCOLE |
Accéder aux résultats |
---|---|---|---|---|---|
Hepatitis A vaccine |
AVAXIM 80U Pediatric Vaccine |
Hepatitis A |
HAF65 |
||
Hepatitis A vaccine |
AVAXIM 160U |
Hepatitis A |
HAF78 |
||
Hepatitis A vaccine |
Avaxim® 80U Pediatric vaccine |
Hepatitis A |
HAF85 |
||
Hepatitis A vaccine |
Avaxim® 80U Pediatric vaccine |
Hepatitis A |
HAF87 |
||
Hepatitis B Vaccine |
HBVAXPRO® |
Hepatitis B |
HXV01C |
||
Hepatitis B Vaccine |
HBVAXPRO® |
Hepatitis B |
HXV02C |
||
Hepatitis B Vaccine |
HBVAXPRO® |
Hepatitis B |
rHB01C |
||
Human Papillomavirus Vaccine |
GARDASIL®9 |
Human papillomavirus infection |
GDS07C |
||
NOM GÉNÉRIQUE | NOM COMMERCIAL |
CONDITION(S) |
CODE ÉTUDE | ACCÉDER AUX ÉTUDES / PROTOCOLE | ACCÉDER AUX RÉSULTATS |
---|---|---|---|---|---|
INACTIVATED POLIOVIRUS VACCINE | Imovax Polio®; Ipol® |
Poliomyelitis |
IPV13 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV17 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV25 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV26 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV29 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV30 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV31 |
Pas encore disponible | |
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV34 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV35 (EFC12403) |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV46 (EFC13614) |
||
INFLUENZA VIRUS VACCINE - CELL BASED |
Not yet identified |
Influenza infection |
GCE03 |
||
INFLUENZA-A VACCINE (RECOMBINANT M2E) |
ACAM FLU-A |
Influenza infection |
H-261-001 |
NOM GÉNÉRIQUE | NOM COMMERCIAL | CONDITION(S) | CODE ÉTUDE | ACCÉDER AUX ÉTUDES / PROTOCOLE | ACCÉDER AUX RÉSULTATS |
---|---|---|---|---|---|
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC01 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC02 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC04 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC05 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC07 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC12 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC13 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC15 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC17 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC18 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC22 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-004 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-005 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-006 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-007 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-008 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-009 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-010 |
NOM GÉNÉRIQUE |
|
CONDITION(S) | CODE ÉTUDE | ACCÉDER AUX ÉTUDES / PROTOCOLE | ACCÉDER AUX RÉSULTATS | |
---|---|---|---|---|---|---|
LIVE ATTENUATED STABILIZED YELLOW FEVER VACCINE |
Stamaril® |
Yellow Fever Virus |
STA10 |
NOM GÉNÉRIQUE | NOM COMMERCIAL |
CONDITION(S) |
CODE ÉTUDE |
ACCÉDER AUX ÉTUDES / PROTOCOLE |
ACCÉDER AUX RÉSULTATS |
---|---|---|---|---|---|
MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE |
ProQuad® |
Measles, Mumps, Rubella, and Varicella |
X06-MMRV-302 |
||
MEASLES, MUMPS AND RUBELLA VACCINE |
ProQuad® |
Measles, Mumps and Rubella |
MRV02C |
||
MELANOMA MULTI-ANTIGEN THERAPEUTIC VACCINE - ALVAC(2) |
Pas encore disponible |
Metastatic Melanoma |
MEL11 |
||
MENINGOCOCCAL AC POLYSACCHARIDE VACCINE |
PS Meningococcal A+C® |
Meningococcal meningitis |
MPS01 |
||
MODIFIED VACCINIA ANKARA (MVA) SMALLPOX VACCINE |
Pas encore disponible |
Smallpox |
H-249-001 |
Pas encore disponible |
|
MODIFIED VACCINIA ANKARA (MVA) SMALLPOX VACCINE |
Pas encore disponible |
Smallpox |
H-249-002 |
Pas encore disponible |
|
MODIFIED VACCINIA ANKARA (MVA) SMALLPOX VACCINE |
Pas encore disponible |
Smallpox |
H-249-004 |
Pas encore disponible |
|
MONOVALENT SUBVIRION A/H1N1 INFLUENZA VACCINE |
Influenza A (H1N1) 2009 monovalent vaccine |
Influenza infection (Swine-origin A/H1N1) |
FUF04 |
||
MONOVALENT SUBVIRION A/H1N1 INFLUENZA VACCINE |
Influenza A (H1N1) 2009 monovalent vaccine |
Influenza infection (Swine-origin A/H1N1) |
FUF14 |
||
MONOVALENT SUBVIRION A/H1N1 INFLUENZA VACCINE |
Influenza A (H1N1) 2009 monovalent vaccine |
Influenza infection (Swine-origin A/H1N1) |
FUF15 |
||
MONOVALENT SUBVIRION A/H1N1 INFLUENZA VACCINE |
Influenza A (H1N1) 2009 monovalent vaccine |
Influenza infection (Swine-origin A/H1N1) |
FUF16 |
NOM GÉNÉRIQUE |
|
CONDITION(S) | CODE ÉTUDE | ACCÉDER AUX ÉTUDES / PROTOCOLE | ACCÉDER AUX RÉSULTATS | |
---|---|---|---|---|---|---|
NA |
NA |
Zika Virus Disease |
VAG00001 |
NOM GÉNÉRIQUE | NOM COMMERCIAL |
CONDITION(S) |
CODE ÉTUDE | ACCÉDER AUX ÉTUDES / PROTOCOLE | ACCÉDER AUX RÉSULTATS |
---|---|---|---|---|---|
ORAL CHOLERA VACCINE |
Shanchol® |
Cholera |
SHC02 |
||
ORAL CHOLERA VACCINE |
Shanchol® |
Cholera |
SHC03 |
||
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
PNEUMOCOCCAL POLYSACCHARIDE VACCINE |
Pneumo 23® |
Pneumococcal Infections |
PNA19 |
||
PNEUMOCOCCAL PROTEIN VACCINE |
Not yet identified |
Pneumococcal Infections |
PPR01 |
||
PNEUMOCOCCAL PROTEIN VACCINE |
Not yet identified |
Pneumococcal Infections |
PPR02 |
Not yet |
|
PNEUMOCOCCAL PROTEIN VACCINE |
Not yet identified |
Pneumococcal Infections |
PPR05 |
||
PNEUMOCOCCAL PROTEIN VACCINE |
Not yet identified |
Pneumococcal Infections |
PPR06 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV01 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV02 |
Not yet |
|
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV04 |
Not yet |
|
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV06 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV08 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV11 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not marketed |
Rabies |
VRV13 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV00014 |
NOM GÉNÉRIQUE | NOM COMMERCIAL |
CONDITION(S) |
CODE ÉTUDE | ACCÉDER AUX ÉTUDES / PROTOCOLE | ACCÉDER AUX RÉSULTATS |
---|---|---|---|---|---|
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM01 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM02 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM04 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM05 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM07 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM09 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM11 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM14 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM00016 |
||
HIGH-DOSE QUADRIVALENT INFLUENZA VACCINE |
Fluzone® High Dose Quadrivalent Vaccine |
Influenza infection |
QHD00008 |
||
HIGH-DOSE QUADRIVALENT INFLUENZA VACCINE |
Fluzone® High Dose Quadrivalent Vaccine |
Influenza infection |
QHD00011 |
||
HIGH-DOSE QUADRIVALENT INFLUENZA VACCINE |
Fluzone® High Dose Quadrivalent Vaccine |
Influenza infection |
QHD00013 |
||
HIGH-DOSE QUADRIVALENT INFLUENZA VACCINE |
Fluzone® High Dose Quadrivalent Vaccine |
Influenza infection |
QHD04 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC00097 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC51 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC52 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC55 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC56 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC57 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC58 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC71 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC73 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC85 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC88 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC90 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
QIV03 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
QIV04 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
QIV06 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
QIV08 |
Pas encore disponible |
|
QUADRIVALENT INACTIVATED INFLUENZA VACCINE - INTRADERMAL |
Fluzone® QIV-ID |
Influenza infection |
QID01 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE - INTRADERMAL |
Fluzone® QIV-ID |
Influenza infection |
QID02 |
||
QUADRIVALENT MENINGOCOCCAL ACYW POLYSACCHARIDE VACCINE |
Menomune® |
Meningococcal meningitis |
MPT01 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET32 |
Pas encore disponible |
|
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET39 |
Pas encore disponible |
|
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET35 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET43 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET44 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET49 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET50 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET51 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET54 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET56 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET57 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET62 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MEQ00066 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA15 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA16 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA17 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA19 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA21 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA23 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA26 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA29 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA30 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA35 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA37 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA38 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA40 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA43 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA44 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA47 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA48 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA51 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA52 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA55 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA57 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA61 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA62 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA64 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA70 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA71 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA73 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA75 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA76 (SFY12080) |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA77 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA79 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA89 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA90 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA92 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA00093 |
||
QUADRIVALENT RECOMBINANT INFLUENZA VACCINE |
FluBlok® |
Influenza |
PSC12 |
||
QUADRIVALENT RECOMBINANT INFLUENZA VACCINE |
FluBlok® |
Influenza |
PSC16 |
NOM GÉNÉRIQUE | NOM COMMERCIAL |
CONDITION(S) |
CODE ÉTUDE | ACCÉDER AUX ÉTUDES / PROTOCOLE | ACCÉDER AUX RÉSULTATS |
---|---|---|---|---|---|
RABIES VACCINE (PURIFIED VEROCELL) |
Verorab® |
Rabies |
RAB28 |
||
RABIES VACCINE (PURIFIED VEROCELL) |
Verorab® |
Rabies |
RAB40 |
||
ROTAVIRUS VACCINE |
RotaTeq® |
Rotavirus infection |
S06-ROT-304 |
NOM GÉNÉRIQUE | NOM COMMERCIAL | CONDITION(S) | CODE ÉTUDE |
|
ACCÉDER AUX RÉSULTATS | |
---|---|---|---|---|---|---|
SARS-COV-2 ADJUVANTED RECOMBINANT PROTEIN VACCINE |
Not Marketed |
COVID-19 (Healthy Volunteers) |
VAT00008 |
Not yet |
||
SMALLPOX VACCINE |
Not yet identified |
Smallpox; Poxvirus Infection |
VVL04 |
|||
SMALLPOX VACCINE |
Not yet identified |
Smallpox; Poxvirus Infection |
VVL05 |
|||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF01 |
|||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF07 |
|||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF08 |
|||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF09 |
|||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF11 |
|||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF14 |
|||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF18 |
NOM GÉNÉRIQUE | NOM COMMERCIAL | CONDITION(S) | CODE ÉTUDE | ACCÉDER AUX ÉTUDES / PROTOCOLE | ACCÉDER AUX RÉSULTATS |
---|---|---|---|---|---|
TDAP VACCINE |
Not yet identified |
Tetanus; Diphtheria; Pertussis |
ADC01 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TC9704-LT |
||
TDAP |
Adacel® / Covaxis® |
Tetanus; Diphtheria; Pertussis |
TD506-LT |
||
TDAP |
Adacel® / Covaxis® |
Tetanus; Diphtheria; Pertussis |
TD508 |
||
TDAP |
Adacel® / Covaxis® |
Tetanus; Diphtheria; Pertussis |
TD511 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD512 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD515 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td516 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td517 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td518 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td519 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td521 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td526 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td527 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td528 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td532 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td533 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td536 (EFC12579) |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td537 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td540 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td551 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD9707-LT |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD9805-LT |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD9809 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD9809-LT |
||
TDAP / TDAP-IPV |
Covaxis® Polio Repevax® |
Pertussis; Diphtheria; Tetanus; Poliomyelitis |
TRI05 |
||
TDAP-IPV |
Adacel® Polio |
Tetanus; Diphtheria; Pertussis; Polio |
Td525 |
||
TETANUS AND DIPHTHERIA TOXOIDS ADSORBED VACCINE |
Tenivac™ |
Diphtheria; Tetanus |
TDC01 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD01 |
|
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD02 |
|
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD04 |
|
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD05 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD06 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD08 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD10 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD11 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD12 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD13 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD14 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD15 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD17 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD22 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD23 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD24 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD28 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD29 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD30 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD32 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD33 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD34 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD35 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD47 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD50 |
Not yet |
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD51 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD56 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD57 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD59 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD63 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD64 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD65 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD66 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD67 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD71 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
DNG10 |
Pas encore disponible |
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
DNG15 |
Pas encore disponible |
|
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID04 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID07 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID21 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID29 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID30 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID31 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID33 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM01 |
|
|
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM05 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM07 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM09 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM12 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
QHD01 |
Pas encore disponible |
|
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Pas encore disponible |
Influenza infection |
FST01 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Pas encore disponible |
Influenza infection |
FST02 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID02 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID15 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID16 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID17 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID18 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID23 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID25 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID26 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID29 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID33 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID34 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID37 |
||
A/H5N1 INFLUENZA VACCINE |
Emerflu™ |
Influenza infection |
GPA02 |
||
A/H5N1 INFLUENZA VACCINE |
Emerflu™ |
Influenza infection |
GPA04 |
||
A/H5N1 INFLUENZA VACCINE |
Emerflu™ |
Influenza infection |
GPA11 |
||
A/H5N1 INFLUENZA VACCINE |
Emerflu™ |
Influenza infection |
GPA12 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC16 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC17 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC20 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC21 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC25 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC26 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC27 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC29 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC32 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC34 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC35 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC37 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC38 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC40 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC41 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC43 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC48 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC49 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC50 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT63 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT82 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT83 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT86 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT90 |
||
TRIVALENT RECOMBINANT INFLUENZA VACCINE |
FluBlok® |
Influenza |
PSC04 |
||
TYPHOID VI POLYSACCHARIDE VACCINE |
Typhim Vi® |
Typhoid Fever |
TYP31 (SFY12079) |
||
NOM GÉNÉRIQUE |
NOM COMMERCIAL |
CONDITION(S) |
CODE ÉTUDE |
ACCÉDER AUX ÉTUDES / PROTOCOLE |
ACCÉDER AUX RÉSULTATS |
---|---|---|---|---|---|
VARICELLA VIRUS VACCINE - LIVE ATTENUATED |
Zostavax® |
Varicella |
VBK12 |
||
VARICELLA VIRUS VACCINE - LIVE ATTENUATED |
Zostavax® |
Varicella |
ZTV03C |
||
NOM GÉNÉRIQUE | NOM COMMERCIAL | CONDITION(S) | CODE ÉTUDE | ACCÉDER AUX ÉTUDES / PROTOCOLE | ACCÉDER AUX RÉSULTATS |
---|---|---|---|---|---|
WEST NILE VACCINE - CHIMERIVAX-WN02 |
Pas encore disponible | West Nile Fever | H-244-003 | ||
WEST NILE VACCINE - CHIMERIVAX-WN02 |
Pas encore disponible | West Nile Fever | H-244-004 |